ARTICLE | Company News
Actelion completes Tracleer NDA submission
November 22, 2000 8:00 AM UTC
Actelion (SWX:ATLN) completed the submission of an NDA to the FDA for its Tracleer bosentan oral endothelin antagonist to treat pulmonary arterial hypertension. ...